Patent · US Expired

Somatostatin analog and uses thereof

US7094753B2 · kind B2 · utility

0Cited by

2References

1Claims

0Family size

Assignee

Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S) SAS · FR

Inventors

Thomas D. Gordon · Medway, US
Barry Morgan · Franklin, US
Michael DeWitt Culler · Gretna, US

Key dates

Filing date	Nov 21, 2002
Grant date	Aug 22, 2006
Priority date	—
Expiry date	May 4, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Claimed is a somatostatin agonist according to formula (I),D-Phe-c(Cys-Tyr(I)-D-Trp-Lys-Val-Cys)-Thr-NH2, (I)or a pharmaceutically acceptable salt thereof, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.